NORDIC PHARMACEUTICALS ApS: Financial statements 2018
CVR: 27430015
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
NORDIC PHARMACEUTICALS ApS (CVR 27430015) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,062,911 and a net result of DKK 34,298 compared with DKK 40,436 the year before. That is an increase of 2.4% compared with the year before. Equity in the 2018 report amounted to DKK 1,263,497. The solvency ratio was 46.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 1,062,911
- Profit/Loss
- DKK 34,298
- Equity
- DKK 1,263,497
- Total Assets
- DKK 2,733,603
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1.1 mio. | 34 t. | 1.3 mio. | 3 |
| 2017 | - | 1 mio. | 40 t. | 1.2 mio. | 3 |
| 2016 | - | 1.4 mio. | 145 t. | 1.2 mio. | 3 |
| 2015 | - | 1.3 mio. | 282 t. | 1 mio. | - |
| 2014 | - | 899 t. | 152 t. | 762 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
NORDIC PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK 1,038,252, and the net result was DKK 40,436.
About NORDIC PHARMACEUTICALS ApS
NORDIC PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2003. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Lars Bo Holløse Nielsen. The board consists of Knud Benny Junge (chair). The company is owned by Lars Bo Holløse Nielsen and Kea Ok Junge. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -165,886 and a net result of DKK -573,072 compared with DKK -2,664,416 the year before. Equity in the 2025 report amounted to DKK -1,725,613.